RE: Crazy12 Feb 2026 19:21
Pass onto the BOD any details you feel you should. I have no issues, in fact I encourage you. Then thew BOD will seee that they have taken approx 20% of all monies raised 75% approx in Salary NIC, Pensions Bonus(shares). And, there is no need to tell them they have delivered nothing of significance for the LTH, they already know that and they can see the SP.
All the data that formed part of the recent posts were furnished from analysis done on Wisesheets, LSE, and Gemini pro. And, I still think they are playing us. Thats my view and I am sticking to it.
The sources of my data was also mentioned on some of the posts if I recall. You or anyone else can go check this, I am surprised you have not already done this yourselves.
Was up at Glenshee today, conditions were excellent thanks to a fresh snow overnight. I went downhill nearly as fast as the QED SP. Then I jumped on the chair and backup I went, like my killing in KEFI, now time to topslice.
quick Gemini Pro deep search
While the company has raised significant funds through numerous "placings" and share issuances to fund its technical development and fuel trials (such as MSAR® and bioMSAR™), the breakdown of expenditure typically looks like this:
Category
Estimated Percentage of Funds
BOD Remuneration~18–20%
Technical Development & Trials~50–60%
General Admin & Operations~20–30%
Context for InvestorsThis figure is often cited by "Long Term Holders" (LTH) who have expressed frustration over the following:Dilution: The frequent need for fundraisers has significantly diluted original shareholdings.Pay vs. Performance:
Critics argue that while the share price has seen a long-term decline (trading around 2.0p – 2.4p in early 2026 from much higher peaks in the mid-2010s), board compensation has remained relatively high.
Commercial Delays: Despite several "near-miss" commercial agreements over the years, the lack of consistent revenue-generating contracts has made the percentage spent on internal salaries a focal point for activist shareholders.Note: These figures are derived from cumulative financial reports and shareholder analysis.